Sakharov and SDI

The comments in your January 26 issue by Medvedev and Ziman about the motives behind the release of Andrei Sakharoy are necessarily speculative, but not exhaustive. Let me add by way of an alternative speculation, based on the fact that Sakharov has expressed criticisms of the feasibility of the Strategic Defense Initiative, that his view on SDI may have contributed to the decision by Gorbachev to release Sakharov at this time. Gorbachev repeatedly has shown his eagerness to discourage our plans

Written byLawrence Cranberg
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Gorbachev repeatedly has shown his eagerness to discourage our plans for SDI, and has already been drawn to the conference tables at Geneva and Reykjavik for that purpose. Given the many substantial reasons he already had to release Sakharov from Gorky, the fact that Sakharov would add his enormous prestige to the critics of SDI might have been an additional factor in tipping the scales in favor of release at this time.

Sakharov's views on SDI have not been reported in any detail in the press, and it may be useful to attach here the transcript of a phone conversation of December 30, 1986, between Sakharov and his American representative and son-in-law Efrem Yankelevich, which the latter has been kind enough to share with me and others.

Nothing in these remarks is to be interpreted as implying that Sakharov's position has been influenced by a desire to accommodate to Gorbachev's ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies